HQL (abrdn Life Sciences Investors) Stock Analysis - SEC Filings

abrdn Life Sciences Investors (HQL) is a publicly traded Financial Services sector company. As of May 21, 2026, HQL trades at $17.23 with a market cap of $537.31M and a P/E ratio of 0.00. HQL moved +1.41% today. Year to date, HQL is +6.90%; over the trailing twelve months it is +38.84%. Its 52-week range spans $10.55 to $18.46. Rallies surfaces HQL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find HQL SEC filings?

Rallies organizes HQL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

HQL Key Metrics

Key financial metrics for HQL
MetricValue
Price$17.23
Market Cap$537.31M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.56%
52-Week High$18.46
52-Week Low$10.55
Volume208
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest HQL News

Recent HQL Insider Trades

  • Pittard Christian bought 7.92K (~$133.75K) on Dec 16, 2025.
  • Saba Capital Management, L.P. sold 41.62K (~$588.55K) on Sep 22, 2025.
  • Saba Capital Management, L.P. sold 6.99K (~$98.54K) on Sep 19, 2025.

HQL Analyst Consensus

HQL analyst coverage data. Average price target: $0.00.

Common questions about HQL

Where can I find HQL SEC filings?
Rallies organizes HQL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show HQL 10-K and 10-Q filings?
Rallies organizes HQL SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is HQL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HQL. It does not provide personalized investment advice.
HQL

HQL